Internet-Assisted Cognitive Behavioral Intervention for Targeted Therapy–Related Fatigue in Chronic Myeloid Leukemia: Results From a Pilot Randomized Trial

Published 2019-09-25 From Cancer 10 authors

Read paper (PDF) ↗ View on Semantic Scholar ↗

Attribution

This is the abstract and citation. Full text lives at Semantic Scholar — we link out rather than host. All credit to the authors and Cancer.

Abstract

Verbatim from Semantic Scholar. Not paraphrased, not summarized.

Fatigue is a common and disabling side effect of targeted therapies such as tyrosine kinase inhibitors (TKIs) used to treat chronic myeloid leukemia (CML). The goal of the current study was to conduct a pilot randomized trial of the first cognitive behavioral intervention developed for fatigue due to targeted therapy.

Authors

H. Jim
K. Hyland
A. Nelson
J. Pinilla-Ibarz
K. Sweet
M. Gielissen
H. Bulls
A. Hoogland
P. Jacobsen
H. Knoop

Keywords

Medicine

Citation: H. Jim, K. Hyland, A. Nelson , et al. (2019). Internet-Assisted Cognitive Behavioral Intervention for Targeted Therapy–Related Fatigue in Chronic Myeloid Leukemia: Results From a Pilot Randomized Trial. Cancer. Semantic Scholar ID cde8a6484c676967255c66970bbd01570bf1c698. https://doi.org/10.1002/cncr.32521 ↗